GSK and Pfizer hold out for £60bn bid for consumer health unit
Investors push for higher price or spin-off after rejecting Unilever’s £50bn offer
Full Article
GSK and Pfizer hold out for £60bn bid for consumer health unit
FT.com
0 shares
1 views
You might like
Related news coverage
Unilever rules out increasing £50bn bid for GSK unit after backlash
FT.com
Plan to buy consumer health business has faced fierce opposition from shareholders